NDC Package 0006-3025-00 Zinplava

Bezlotoxumab Injection, Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0006-3025-00
Package Description:
1 VIAL, SINGLE-DOSE in 1 CARTON / 40 mL in 1 VIAL, SINGLE-DOSE (0006-3025-01)
Product Code:
Proprietary Name:
Zinplava
Non-Proprietary Name:
Bezlotoxumab
Substance Name:
Bezlotoxumab
Usage Information:
ZINPLAVA™ is indicated to reduce recurrence of Clostridium difficile infection (CDI) in patients 18 years of age or older who are receiving antibacterial drug treatment of CDI and are at a high risk for CDI recurrence.
11-Digit NDC Billing Format:
00006302500
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1855052 - bezlotoxumab 1000 MG in 40 ML Injection
  • RxCUI: 1855052 - 40 ML bezlotoxumab 25 MG/ML Injection
  • RxCUI: 1855052 - bezlotoxumab 1000 MG per 40 ML Injection
  • RxCUI: 1855057 - Zinplava 1000 MG in 40 ML Injection
  • RxCUI: 1855057 - 40 ML bezlotoxumab 25 MG/ML Injection [Zinplava]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Merck Sharp & Dohme Llc
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    BLA761046
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    10-21-2016
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0006-3025-00?

    The NDC Packaged Code 0006-3025-00 is assigned to a package of 1 vial, single-dose in 1 carton / 40 ml in 1 vial, single-dose (0006-3025-01) of Zinplava, a human prescription drug labeled by Merck Sharp & Dohme Llc. The product's dosage form is injection, solution and is administered via intravenous form.

    Is NDC 0006-3025 included in the NDC Directory?

    Yes, Zinplava with product code 0006-3025 is active and included in the NDC Directory. The product was first marketed by Merck Sharp & Dohme Llc on October 21, 2016 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0006-3025-00?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 0006-3025-00?

    The 11-digit format is 00006302500. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20006-3025-005-4-200006-3025-00